Autogenous Particles Harvesting During Implant Surgery
Launched by UNIVERSIDAD DE MURCIA · Jan 31, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different ways to collect bone particles during dental implant surgery. The researchers want to find out which method works best to promote the growth and healing of bone cells, called osteoblasts, that help support dental implants. They will use two techniques: one with low-speed drilling and another with high-speed drilling. By studying how well the bone particles help the cells grow, the goal is to improve the success of dental implants for people who have lost teeth.
To participate in this trial, you need to be an adult who can give consent and have been missing certain teeth in your lower jaw for at least three months. You should also have healthy bone density in that area and no serious medical conditions that could affect healing, like uncontrolled diabetes or certain medications that impact bone health. While the trial is not yet recruiting participants, those who join can expect to undergo a dental procedure where bone particles are collected and studied to help improve future dental implant surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Legal age
- • Informed consent signed
- • Bilateral mandibular dental absence of 3.6 and 4.6 for more than 3 months
- • Normal bone density in the posterior mandibular sector with type II/III bone (range of 500-850 HU) according to the classification of Norton and Gamble
- • No medical contraindications for the performance of oral surgical procedures (ASA I/II).
- Exclusion Criteria:
- • Presence of any disease, condition, or medication that may compromise the healing and/or osseointegration of dental implants (such as diabetes mellitus, bisphosphonate administration, or severe osteoporosis)
- • Presence of any severe mental disorder
- • Patients who have undergone head and neck radiotherapy in the previous 18 months.
About Universidad De Murcia
The Universidad de Murcia, a leading academic institution in Spain, is dedicated to advancing medical research and innovation through its clinical trial initiatives. With a strong emphasis on interdisciplinary collaboration and patient-centered approaches, the university conducts rigorous clinical studies aimed at improving health outcomes and contributing to the scientific community. Its skilled team of researchers and healthcare professionals are committed to adhering to the highest ethical standards and regulatory guidelines, ensuring that each trial not only furthers medical knowledge but also prioritizes participant safety and well-being. Through its clinical trials, the Universidad de Murcia strives to translate research findings into practical applications that enhance healthcare practices and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported